NovoCure Ltd Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NovoCure Ltd quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
  • NovoCure Ltd Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $31.4M, a 19% increase year-over-year.
  • NovoCure Ltd Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $115M, a 10.3% decline year-over-year.
  • NovoCure Ltd annual Share-based Payment Arrangement, Expense for 2023 was $116M, a 8.09% increase from 2022.
  • NovoCure Ltd annual Share-based Payment Arrangement, Expense for 2022 was $107M, a 12.7% increase from 2021.
  • NovoCure Ltd annual Share-based Payment Arrangement, Expense for 2021 was $94.9M, a 25.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $116M +$8.65M +8.09% Jan 1, 2023 Dec 31, 2023 10-Q 2024-10-30
2022 $107M +$12.1M +12.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $94.9M +$19.2M +25.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $75.7M +$23.3M +44.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $52.4M +$12.6M +31.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $39.8M +$12.7M +46.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $27.1M +$5.68M +26.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $21.4M +$9.58M +80.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $11.9M +$7.24M +156% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $4.62M -$496K -9.69% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $5.12M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.